title: Simulating pharmacokinetic and pharmacodynamic fuzzy-parameterized models: a comparison of numerical methods.
abstract: Statistical techniques have been traditionally used to deal with parametric variation in pharmacokinetic and pharmacodynamic models, but these require substantial data for estimates of probability distributions. In the presence of limited, inaccurate or imprecise information, simulation with fuzzy numbers represents an alternative tool to handle parametric uncertainty. Existing methods for implementing fuzzy arithmetic may, however, have significant shortcomings in overestimating (e.g., conventional fuzzy arithmetic) and underestimating (e.g., vertex method) the output uncertainty. The purpose of the present study is to apply and compare the applicability of conventional fuzzy arithmetic, vertex method and two recently proposed numerical schemes, namely transformation and optimization methods, for uncertainty modeling in pharmacokinetic and pharmacodynamic fuzzy-parameterized systems. A series of test problems were examined, including empirical pharmacokinetic and pharmacodynamic models, a function non-monotonic in its parameters, and a whole body physiologically based pharmacokinetic model. Our results verified that conventional fuzzy arithmetic can lead to overestimation of response uncertainty and should be avoided. For the monotonic pharmacokinetic and pharmacodynamic models, the vertex method accurately predicted fuzzy-valued output while incurring the least computational cost. It turned out that the choice of a suitable method for fuzzy simulation of the non-monotonic function depended on the required accuracy of the results: the vertex method was capable of eliciting an initial approximate solution with few function evaluations; for more accurate results, the transformation method was the most superior approach in terms of accuracy per unit CPU time.
authors: Resource Facility for Population Kinetics, Department of Bioengineering, University of Washington, Box 355061, Seattle, WA 98195-5061, USA.
authors: Kok-Yong
authors: KY
authors: Seng
authors: Ivan
authors: I
authors: Nestorov
authors: Paolo
authors: P
authors: Vicini
mesh_terms: D003198:Computer Simulation; D017143:Fuzzy Logic; D008433:Mathematics; D008954:Models, Biological; D010599:Pharmacokinetics; D010600:Pharmacology
references: J Appl Physiol (1985). 1993 Jan;74(1):203-10
references: 8444692
references: Adv Space Res. 2004;34(6):1383-9
references: 15881779
references: Clin Cancer Res. 2004 Dec 1;10 (23 ):8048-58
references: 15585640
references: J Pharmacokinet Biopharm. 1983 Dec;11(6):577-93
references: 6678311
references: Br J Clin Pharmacol. 2002 Oct;54(4):407-14
references: 12392589
references: Risk Anal. 2002 Feb;22(1):67-81
references: 12017363
references: J Pharmacokinet Biopharm. 1994 Oct;22(5):381-410
references: 7791038
references: Antimicrob Agents Chemother. 2006 Jul;50(7):2344-51
references: 16801411
references: Pharmacol Ther. 1982;16(2):143-66
references: 6752972
references: Clin Pharmacokinet. 2007;46(2):159-73
references: 17253886
references: J Pharmacokinet Pharmacodyn. 2002 Aug;29(4):339-63
references: 12518708
references: J Pharmacokinet Pharmacodyn. 2004 Jun;31(3):185-213
references: 15518244
references: Environ Toxicol Chem. 2006 Aug;25(8):2227-36
references: 16916043
references: Toxicol Lett. 2001 Mar 31;120(1-3):411-20
references: 11323201